Replies to post #156595 on Biotech Values

[DewDiligence]

1Q13 US Copaxone sales reported by Teva were $806M, +17% YoY and -2% QoQ:

http://finance.yahoo.com/news/teva-reports-first-quarter-2013-110000879.html